General Information of the Compound
Compound ID
CP0415303
Compound Name
N-hydroxy-6-[(3S,6R,9S,12R)-2,5,8,11-tetraoxo-6,9-dipentyl-1,4,7,10-tetrazabicyclo[10.3.0]pentadecan-3-yl]hexanamide
    Show/Hide
Structure
Formula
C27H47N5O6
Molecular Weight
537.702
Canonical SMILES
CCCCC[C@@H]1NC(=O)[C@H]2CCCN2C(=O)[C@H](CCCCCC(=O)NO)NC(=O)[C@@H](CCCCC)NC1=O
    Show/Hide
InChI
InChI=1S/C27H47N5O6/c1-3-5-8-13-19-25(35)30-21(15-10-7-11-17-23(33)31-38)27(37)32-18-12-16-22(32)26(36)29-20(24(34)28-19)14-9-6-4-2/h19-22,38H,3-18H2,1-2H3,(H,28,34)(H,29,36)(H,30,35)(H,31,33)/t19-,20+,21+,22-/m1/s1
    Show/Hide
InChIKey
IAXSAHXPKHCCRC-CLAROIROSA-N
Physicochemical Property
logP
2.0619
Rotatable Bonds
14
Heavy Atom Count
38
Polar Areas
156.94
Hydrogen Bond Donor Count
5
Hydrogen Bond Acceptor Count
6
Complexity
38

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 118721286
ChEMBL ID
CHEMBL3356087
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00991, Histone deacetylase 1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000025 HEK-293T Homo sapiens (Human)  1
1
IC50 = 43 nM
   TI
   LI
   LO
   TS
Protein ID: PT00994, Histone deacetylase 4
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000025 HEK-293T Homo sapiens (Human)  1
1
IC50 = 43 nM
   TI
   LI
   LO
   TS
Protein ID: PT03064, Histone deacetylase 6
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000025 HEK-293T Homo sapiens (Human)  1
1
IC50 = 570 nM
   TI
   LI
   LO
   TS